-
Sanofi’s insulin lispro receives CHMP positive opinion to treat diabetes
pharmaceutical-technology
May 27, 2017
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the marketing authorisation of Sanofi's insulin lispro.
-
Merck's Glucophage? SR Receives Label Extension for Patients at High Risk of Type 2 Diabetes in the
en-cphi.cn
May 18, 2017
Merck, a leading science and technology company, today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has authorized Glucophage? SR (sustained release formulation; metformin)...
-
Actress Angela Bassett joins For Your SweetHeart? to urge people with diabetes to know their heart d
lilly
May 17, 2017
Bassett encourages people with type 2 diabetes and their loved ones to take and share the Heart You Quiz to learn more about the No. 1 killer of people with this condition
-
Next generation diabetes therapy and drug delivery market expected to reach US$9,673 million, global
pharmaasia
May 02, 2017
Next generation diabetes therapy and drug delivery devices are used to check the blood glucose levels and deliver insulin into the body.
-
Type 2 Diabetes May Be Bad for Brain Health
drugs.com
April 28, 2017
Previous research has linked type 2 diabetes and memory loss. Now, new research may be closing in on some of the reasons why.
-
GeNeuro initiates Phase 2a study in Australia to treat Type 1 Diabetes
europeanpharmaceuticalreview
April 20, 2017
GeNeuro, a biopharmaceutical company developing new treatments for neurological disorders and autoimmune diseases, have started a Phase 2a clinical study in Australia with GNbAC1 in patients with Type 1 diabetes.
-
Plant protein may protect against type II diabetes, meat eaters at greater risk: Study
financialexpress
April 20, 2017
Source of dietary protein may play a role in the risk of developing type-II diabetes
-
SCIENCE CHINA Life Sciences English Edition Publishes Domestic Type 2 Diabetes Research Findings
en-cphi.cn
April 17, 2017
SCIENCE CHINA Life Sciences, a scientific journal sponsored by the Chinese Academy of Sciences and the National Natural Science Foundation of China...
-
Evotec Achieves Sanofi Diabetes Milestone
contractpharma
April 07, 2017
Achieves preclinical proof-of-concept, triggering €3.0 million payment
-
Once-weekly semaglutide demonstrated consistent blood glucose reductions and weight loss regardless
worldpharmanews
April 05, 2017
Findings from a post hoc analysis of the phase 3a SUSTAIN 2-4 trials demonstrated greater mean reductions in HbA1c and body weight with once-weekly semaglutide treatment compared to sitagliptin...
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
